High dimensional proteomic mapping of bone marrow immune characteristics in immune thrombocytopenia

被引:0
|
作者
FengQi Liu [1 ,2 ,3 ,4 ]
QingYuan Qu [1 ,2 ,3 ,4 ]
Ying Lei [5 ,6 ]
Qi Chen [1 ,2 ,3 ,4 ]
YuXiu Chen [1 ,2 ,3 ,4 ]
MengLin Li [1 ,2 ,3 ,4 ]
XueYan Sun [1 ,2 ,3 ,4 ]
YeJun Wu [1 ,2 ,3 ,4 ]
QiuSha Huang [1 ,2 ,3 ,4 ]
HaiXia Fu [1 ,2 ,3 ,4 ]
Yuan Kong [1 ,2 ,3 ,4 ]
YueYing Li [5 ,6 ]
QianFei Wang [5 ,6 ]
XiaoJun Huang [1 ,2 ,3 ,4 ,7 ,8 ]
XiaoHui Zhang [1 ,2 ,3 ,4 ]
机构
[1] Peking University People's Hospital,Peking University Institute of Hematology
[2] Beijing Key Laboratory of Hematopoietic Stem Cell Transplantation
[3] National Clinical Research Center for Hematologic Disease
[4] Collaborative Innovation Centre of Hematology,Peking University
[5] CAS Key Laboratory of Genomic and Precision Medicine,Beijing Institute of Genomics,Chinese Academy of Sciences and China National Center for Bioinformation
[6] University of Chinese Academy of Sciences
[7] Peking-Tsinghua Center for Life Sciences,Academy for Advanced Interdisciplinary Studies,Peking University
[8] State Key Laboratory of Natural and Biomimetic Drugs,Peking
关键词
D O I
暂无
中图分类号
学科分类号
摘要
To investigate the role of co-stimulatory and co-inhibitory molecules on immune tolerance in immune thrombocytopenia(ITP),this study mapped the immune cell heterogeneity in the bone marrow of ITP at the single-cell level using Cytometry by Time of Flight(Cy TOF).Thirty-six patients with ITP and nine healthy volunteers were enrolled in the study.As soluble immunomodulatory molecules,more s CD25 and s Galectin-9 were detected in ITP patients.On the cell surface,co-stimulatory molecules like ICOS and HVEM were observed to be upregulated in mainly central memory and effector T cells.In contrast,co-inhibitory molecules such as CTLA-4 were significantly reduced in Th1and Th17 cell subsets.Taking a platelet count of 30×109L-1as the cutoff value,ITP patients with high and low platelet counts showed different T cell immune profiles.Antigen-presenting cells such as monocytes and B cells may regulate the activation of T cells through CTLA-4/CD86 and HVEM/BTLA interactions,respectively,and participate in the pathogenesis of ITP.In conclusion,the proteomic and soluble molecular profiles brought insight into the interaction and modulation of immune cells in the bone marrow of ITP.They may offer novel targets to develop personalized immunotherapies.
引用
下载
收藏
页码:1635 / 1647
页数:13
相关论文
共 50 条
  • [31] ANALYSIS OF BASELINE BONE MARROW CHARACTERISTICS IN A LONGITUDINAL 2-YEAR BONE MARROW STUDY OF ELTROMBOPAG IN PREVIOUSLY TREATED PATIENTS WITH CHRONIC IMMUNE THROMBOCYTOPENIA
    Brynes, R.
    Orazi, A.
    Bakshi, K.
    Bailey, C.
    Brainsky, A.
    HAEMATOLOGICA, 2012, 97 : 197 - 197
  • [32] Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia
    Janssens, Ann
    Rodeghiero, Francesco
    Anderson, David
    Chong, Beng H.
    Boda, Zoltan
    Pabinger, Ingrid
    Cervinek, Libor
    Terrell, Deirdra R.
    Wang, Xuena
    Franklin, Janet
    ANNALS OF HEMATOLOGY, 2016, 95 (07) : 1077 - 1087
  • [33] Changes in bone marrow morphology in adults receiving romiplostim for the treatment of thrombocytopenia associated with primary immune thrombocytopenia
    Ann Janssens
    Francesco Rodeghiero
    David Anderson
    Beng H. Chong
    Zoltán Boda
    Ingrid Pabinger
    Libor Červinek
    Deirdra R. Terrell
    Xuena Wang
    Janet Franklin
    Annals of Hematology, 2016, 95 : 1077 - 1087
  • [34] United Kingdom immune thrombocytopenia registry: retrospective evaluation of bone marrow fibrosis in adult patients with primary immune thrombocytopenia and correlation with clinical findings
    Rizvi, Hasan
    Butler, Tom
    Calaminici, Mariarita
    Doobaree, Indraraj U.
    Nandigam, Raghava C.
    Bennett, Dimitri
    Provan, Drew
    Newland, Adrian C.
    BRITISH JOURNAL OF HAEMATOLOGY, 2015, 169 (04) : 590 - 594
  • [35] High Dimensional Single-Cell Profiling Identifies Immune and Metabolic Heterogeneity in Immune Thrombocytopenia
    Yang, Li-Ping
    Fu, Hai-Xia
    Zhao, Peng
    Wu, Jin
    Huang, Qiu-Sha
    Zhang, Yuan-Yuan
    Kong, Jun
    Wang, Zhi-Dong
    Liu, Jing
    Liu, Kaiyan
    Huang, Xiao Jun
    Zhang, Xiaohui
    BLOOD, 2023, 142
  • [36] Concomitant immune thrombocytopenia and bone marrow hemophagocytosis in a patient with SARS-CoV-2
    Michaelis, Simon
    Pichler, Angelika
    Stelzer, Ingeborg
    Tinchon, Christoph
    Enko, Dietmar
    CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2021, 59 (09) : E358 - E361
  • [37] CHARACTERIZATION OF PATIENTS WITH IMMUNE THROMBOCYTOPENIA (ITP) ENTERING REMISSION IN A ROMIPLOSTIM BONE MARROW STUDY
    Janssens, A.
    Cervinek, L.
    Tejeda Romero, M.
    Wang, X.
    Eisen, M.
    HAEMATOLOGICA, 2016, 101 : 138 - 139
  • [38] Evaluation of bone marrow reticulin formation in chronic immune thrombocytopenia patients treated with romiplostim
    Kuter, David J.
    Mufti, Ghulam J.
    Bain, Barbara J.
    Hasserjian, Robert P.
    Davis, Wende
    Rutstein, Mark
    BLOOD, 2009, 114 (18) : 3748 - 3756
  • [39] Predictors for and outcomes after bone marrow biopsy in Scandinavian patients with chronic immune thrombocytopenia
    Gotschalck, Madeleine Andersson
    Norgaard, Mette
    Risbo, Nickolaj
    Christiansen, Christian Fynbo
    Bahmanyar, Shahram
    Ghanima, Waleed
    Alam, Naufil
    Frederiksen, Henrik
    Nielson, Carrie M.
    Sorensen, Henrik Toft
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2021, 107 (01) : 145 - 156
  • [40] Knowledge mapping of immune thrombocytopenia: a bibliometric study
    Wu, Feifeng
    Li, Cuifang
    Mao, Jueyi
    Zhu, Junquan
    Wang, Yang
    Wen, Chuan
    FRONTIERS IN IMMUNOLOGY, 2023, 14